Key result
Among patients with type 2 diabetes, depression was associated with significantly lower cognitive function as measured by MoCA scores (23.21 vs 26.34, P<0.05).
Why the study?
The study was conducted to evaluate the relationship between depression and dementia in patients with type 2 diabetes mellitus.
Does depression increase the risk of cognitive impairment and dementia in patients with type 2 diabetes?
Observational (n=102)
Does depression increase the risk of cognitive impairment and dementia in patients with type 2 diabetes?
Absolute Event Rate: 23.21% vs 26.34%
p-value: p=<0.05
In patients with type 2 diabetes, depression is associated with worse cognitive function and higher systemic inflammation, suggesting a link between depression and dementia risk.
Depression may raise dementia risk in type 2 diabetes via inflammation; hypothesis-generating and requires prospective confirmation before clinical use.
Objective: The aim of this study is to detect the relation between depression and dementia in patients with type 2 diabetes mellitus (DM). Methods: Clinically diagnosed Type 2 diabetes underwent screening for depression using Beck's Depression Inventory scale and subsequent risk of dementia defined using medical reports, prescription data and death certificates. The mediating act of inflammation systemically was measured by assessing three inflammatory markers (C reactive protein, ESR and Fibrinogen). Results: The study was conducted on 102 diabetic type 2 patients, included 48 males and 54 females. Patients divided into 12 (11.7%) patients with depression and 90 (88.3%) patients without depression (mean age 61±8.6 and 60.9±9.2 respectively). Mean BMI (body mass index) in depressive patients was 33.5 ± 9.3 and was 31.9 ± 8.9 in non-depressive cases (P value 0.01). There were no significant differences in patients with and without depression regarding the presence of hypertension, hyperlipidemia and smoking as risk factors of dementia. Patients with depression had significant impaired cognition and the total MoCA (Montereal Cognitive Assessment) scores were significantly lower than those of patients without depression (23.21 ± 3.48 vs 26.34 ± 3.78, P <0.05). Complication of diabetes in patients with depression as neuropathy was significant (P value 0.005). Other complications as diabetic retinopathy and nephropathy were non-significant. Inflammatory markers levels in patients with depressive symptoms were significantly higher (P value < 0.01). Conclusion: In patients with type 2 diabetes, there is an important association between dementia and depression. Systemic inflammation had a significant role in the relation between depression and dementia.
No takes yet. Share an insight, caveat, or question.
Egila et al. (2022) conducted an observational in Type 2 diabetes mellitus (n=102). Depression vs. No depression was evaluated on Total MoCA (Montreal Cognitive Assessment) score (p=<0.05). Among patients with type 2 diabetes, depression was associated with significantly lower cognitive function as measured by MoCA scores (23.21 vs 26.34, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: